Your browser doesn't support javascript.
loading
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial.
Wiviott, Stephen D; Raz, Itamar; Bonaca, Marc P; Mosenzon, Ofri; Kato, Eri T; Cahn, Avivit; Silverman, Michael G; Bansilal, Sameer; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John Ph; Gause-Nilsson, Ingrid Am; Langkilde, Anna Maria; Johansson, Peter A; Sabatine, Marc S.
Afiliación
  • Wiviott SD; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA. Electronic address: swiviott@partners.org.
  • Raz I; The Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Bonaca MP; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.
  • Mosenzon O; The Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Kato ET; Kyoto University Hospital, Kyoto, Japan.
  • Cahn A; The Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Silverman MG; Cardiology Division, Massachusetts General Hospital, Boston, MA.
  • Bansilal S; Zena and Michael A Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Bhatt DL; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.
  • Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Ontario, Canada.
  • McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Wilding JP; Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
  • Gause-Nilsson IA; AstraZeneca Gothenburg, Mölndal, Sweden.
  • Langkilde AM; AstraZeneca Gothenburg, Mölndal, Sweden.
  • Johansson PA; AstraZeneca Gothenburg, Mölndal, Sweden.
  • Sabatine MS; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.
Am Heart J ; 200: 83-89, 2018 06.
Article en En | MEDLINE | ID: mdl-29898853

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Diabetes Mellitus Tipo 2 / Glucósidos / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Bencidrilo / Diabetes Mellitus Tipo 2 / Glucósidos / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article